Nikola Holtkamp

1.1k total citations
27 papers, 814 citations indexed

About

Nikola Holtkamp is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nikola Holtkamp has authored 27 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 12 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nikola Holtkamp's work include Neurofibromatosis and Schwannoma Cases (12 papers), Sarcoma Diagnosis and Treatment (9 papers) and Prion Diseases and Protein Misfolding (4 papers). Nikola Holtkamp is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (12 papers), Sarcoma Diagnosis and Treatment (9 papers) and Prion Diseases and Protein Misfolding (4 papers). Nikola Holtkamp collaborates with scholars based in Germany, France and Canada. Nikola Holtkamp's co-authors include Andreas von Deimling, Christian Hartmann, Reinhard E. Friedrich, Michael Baier, Armin Kurtz, Christian Mawrin, David Reuß, Elke Malzer, Isis Atallah and Ali Fuat Okuducu and has published in prestigious journals such as The Lancet, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Nikola Holtkamp

27 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikola Holtkamp Germany 19 350 341 240 126 98 27 814
Mingzhe Zheng China 19 497 1.4× 287 0.8× 75 0.3× 91 0.7× 155 1.6× 43 1.1k
Peter Dirks Canada 15 295 0.8× 424 1.2× 114 0.5× 240 1.9× 73 0.7× 31 935
Patricia Thompson United States 12 571 1.6× 405 1.2× 137 0.6× 177 1.4× 57 0.6× 22 1.1k
Fei‐Yu Han Sweden 8 263 0.8× 362 1.1× 63 0.3× 63 0.5× 40 0.4× 11 654
Víctor Martínez‐Glez Spain 22 603 1.7× 161 0.5× 87 0.4× 119 0.9× 157 1.6× 61 1.4k
Catherine Sweeney Ireland 11 493 1.4× 107 0.3× 113 0.5× 43 0.3× 114 1.2× 11 819
Gerrit H. Gielen Germany 18 378 1.1× 230 0.7× 174 0.7× 591 4.7× 157 1.6× 45 979
Vincent Abramowski France 16 555 1.6× 309 0.9× 154 0.6× 50 0.4× 81 0.8× 23 1.1k
Michal Yalon Israel 18 451 1.3× 228 0.7× 87 0.4× 302 2.4× 254 2.6× 43 945
Roberta Sestini Italy 22 595 1.7× 404 1.2× 208 0.9× 64 0.5× 207 2.1× 45 1.3k

Countries citing papers authored by Nikola Holtkamp

Since Specialization
Citations

This map shows the geographic impact of Nikola Holtkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikola Holtkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikola Holtkamp more than expected).

Fields of papers citing papers by Nikola Holtkamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikola Holtkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikola Holtkamp. The network helps show where Nikola Holtkamp may publish in the future.

Co-authorship network of co-authors of Nikola Holtkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Nikola Holtkamp. A scholar is included among the top collaborators of Nikola Holtkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikola Holtkamp. Nikola Holtkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Sujin, Birgit Sawitzki, Lan Kluwe, et al.. (2013). Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Medicine. 11(1). 109–109. 37 indexed citations
2.
Hartmann, Christian, Armin Kurtz, Michael Baier, et al.. (2012). Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours. PLoS ONE. 7(11). e47595–e47595. 42 indexed citations
3.
4.
Heppner, Frank L., et al.. (2010). The 4q12 Amplicon in Malignant Peripheral Nerve Sheath Tumors: Consequences on Gene Expression and Implications for Sunitinib Treatment. PLoS ONE. 5(7). e11858–e11858. 22 indexed citations
5.
Riemer, Constanze, et al.. (2009). Neuroinflammation in Prion Diseases: Concepts and Targets for Therapeutic Intervention. CNS & Neurological Disorders - Drug Targets. 8(5). 329–341. 14 indexed citations
6.
Tallen, Gesche, Nikola Holtkamp, Keiko Suzuki, et al.. (2009). The Inhibitor of Growth 1 (ING1) Proteins Suppress Angiogenesis and Differentially Regulate Angiopoietin Expression in Glioblastoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(2). 95–105. 12 indexed citations
7.
Holtkamp, Nikola, Elke Malzer, Ali Fuat Okuducu, et al.. (2008). EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy. Neuro-Oncology. 10(6). 946–957. 65 indexed citations
8.
Holtkamp, Nikola, et al.. (2007). Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells. Clinical & Experimental Metastasis. 24(1). 57–66. 35 indexed citations
9.
Holtkamp, Nikola, et al.. (2007). Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme. Neuro-Oncology. 9(3). 291–297. 45 indexed citations
10.
Truß, Matthias, Sven Wellmann, Ulrike Laß, et al.. (2007). Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. Journal of Neuro-Oncology. 86(1). 23–30. 8 indexed citations
11.
Holtkamp, Nikola, Ali Fuat Okuducu, Christian Hartmann, et al.. (2005). Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity. Carcinogenesis. 27(3). 664–671. 69 indexed citations
12.
Holtkamp, Nikola, et al.. (2005). Brain slice invasion model reveals genes differentially regulated in glioma invasion. Biochemical and Biophysical Research Communications. 336(4). 1227–1233. 20 indexed citations
13.
Hartmann, Christian, et al.. (2005). PIK3CA mutations in glioblastoma multiforme. Acta Neuropathologica. 109(6). 639–642. 72 indexed citations
14.
Holtkamp, Nikola, David Reuß, Isis Atallah, et al.. (2004). Subclassification of Nerve Sheath Tumors by Gene Expression Profiling. Brain Pathology. 14(3). 258–264. 32 indexed citations
15.
Hartmann, Christian, Astrid Nümann, Wolf Mueller, et al.. (2004). Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. International Journal of Cancer. 108(6). 839–844. 24 indexed citations
16.
Burwinkel, Michael, Nikola Holtkamp, & Michael Baier. (2004). Biology of infectious proteins: lessons from yeast prions. The Lancet. 364(9444). 1471–1472. 3 indexed citations
17.
Harder, Anja, David Reuß, Nikola Holtkamp, et al.. (2004). Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. European Journal of Cancer. 40(18). 2820–2828. 25 indexed citations
18.
Holtkamp, Nikola, Reinhard E. Friedrich, Anja Harder, et al.. (2003). Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors. Acta Neuropathologica. 107(2). 159–168. 37 indexed citations
19.
Mr, Bobkova, Michael Baier, Jörn Stitz, et al.. (2000). Targeting Human T Cells by Retroviral Vectors Displaying Antibody Domains Selected from a Phage Display Library. Human Gene Therapy. 11(2). 293–303. 37 indexed citations
20.
Holtkamp, Nikola, et al.. (2000). Unexpected Coreceptor Usage of Primary Human Immunodeficiency Virus Type 1 Isolates from Viremic Patients under Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 181(2). 513–521. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingzhe Zheng Breakdown of academic impact, for papers by Peter Dirks Breakdown of academic impact, for papers by Patricia Thompson Breakdown of academic impact, for papers by Fei‐Yu Han Breakdown of academic impact, for papers by Víctor Martínez‐Glez Breakdown of academic impact, for papers by Catherine Sweeney Breakdown of academic impact, for papers by Gerrit H. Gielen Breakdown of academic impact, for papers by Vincent Abramowski Breakdown of academic impact, for papers by Michal Yalon Breakdown of academic impact, for papers by Roberta Sestini
Rankless by CCL
2026